Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€43.01

€43.01

-3.890%
-1.78
-3.890%
€88.09
 
22.02.24 / Tradegate WKN: A3DNGX / Symbol: QDEL / Name: QuidelOrtho / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

QuidelOrtho Corp. Stock

Heavy losses for QuidelOrtho Corp. today as the stock fell by -€1.780 (-3.890%).
With 6 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
Based on the current price of 43.01 € the target price of 88 € shows a potential of 104.6% for QuidelOrtho Corp. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the QuidelOrtho Corp. stock. Criterium "Innovation" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.

Pros and Cons of QuidelOrtho Corp. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
B****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of QuidelOrtho Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
QuidelOrtho Corp. -3.890% 10.908% -33.131% -49.400% -36.582% -68.606% -
Boston Scientific 0.450% 1.375% 10.296% 39.162% 20.373% 89.880% 74.915%
Illumina Inc. -0.280% -7.622% -6.710% -34.052% -4.358% -66.494% -54.346%
Waters Corp. 0.650% 1.987% 6.944% 1.116% 1.987% 33.913% 47.722%

Comments

Prediction Buy
Perf. (%) -1.01%
Target price 75.484
Change
Ends at 14.02.25

QuidelOrtho Co. (NASDAQ: QDEL) had its price target lowered by analysts at Royal Bank of Canada from $130.00 to $81.00. They now have an "outperform" rating on the stock.
Ratings data for QDEL provided by MarketBeat
Show more

Prediction Sell
Perf. (%) 2.70%
Target price 34.543
Change
Ends at 14.02.25

QuidelOrtho Co. (NASDAQ: QDEL) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $37.00 price target on the stock, down previously from $66.00.
Ratings data for QDEL provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 2.70%
Target price 70.954
Change
Ends at 14.02.25

QuidelOrtho Co. (NASDAQ: QDEL) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $76.00 price target on the stock, down previously from $100.00.
Ratings data for QDEL provided by MarketBeat
Show more

News

QuidelOrtho Announces Changes in Executive Leadership: https://mms.businesswire.com/media/20240221157769/en/2040201/5/1x1-robert-bujarski_1-1.jpg
QuidelOrtho Announces Changes in Executive Leadership


The Board of Directors (the “Board”) of QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”) has made significant decisions aimed to enhance operational efficiency, drive revenue

Why QuidelOrtho Stock Is Crashing Today: https://g.foolcdn.com/editorial/images/765312/young-man-worried-laptop.jpg
Why QuidelOrtho Stock Is Crashing Today

Shares of QuidelOrtho (NASDAQ: QDEL) were crashing 31.4% lower as of 11:30 a.m. ET on Wednesday. The huge decline came after the in vitro diagnostics company announced its 2023 full-year and

QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results


QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and